ENS 51189

v t e ENS Event
05:00 Jun 19, 2015
Title	Lost Shipment of I-123
Event Description	On 06/8/15, a shipment of I-123, 1.4 mCi, used for diagnostic imaging, was shipped from the Mallinckrodt Maryland Heights, MO facility for overnight delivery via highway carrier to a company located in Baltimore, MD. The material was not received in Maryland as scheduled. The shipper, carrier and customer performed searches. The shipper concluded that the material was missing as of 6/19/15. The half-life of I-123 is 13.3 hours3.472222e-5 days <br />8.333333e-4 hours <br />4.960317e-6 weeks <br />1.1415e-6 months <br />. The licensee will submit a written report within the 30 day requirement. THIS MATERIAL EVENT CONTAINS A "LESS THAN CAT 3" LEVEL OF RADIOACTIVE MATERIAL Sources that are "Less than IAEA Category 3 sources," are either sources that are very unlikely to cause permanent injury to individuals or contain a very small amount of radioactive material that would not cause any permanent injury. Some of these sources, such as moisture density gauges or thickness gauges that are Category 4, the amount of unshielded radioactive material, if not safely managed or securely protected, could possibly - although it is unlikely - temporarily injure someone who handled it or were otherwise in contact with it, or who were close to it for a period of many weeks. For additional information go to http://www-pub.iaea.org/MTCD/publications/PDF/Pub1227_web.pdf

ENS 51189 +/-
Where
Mallinckrodt Pharmaceuticals Maryland Heights, Missouri (NRC Region 3)
License number:	24-04206-01
Organization:	Mallinckrodt Pharmaceuticals
Reporting

10 CFR 20.2201(a)(1)(ii)
Time - Person (Reporting Time:+249.75 h10.406 days <br />1.487 weeks <br />0.342 months <br />)
Opened:	Manuel Diaz 14:45 Jun 29, 2015
NRC Officer:	Steve Sandin
Last Updated:	Jun 29, 2015
51189 - NRC Website
v • d • e

v t e Emergency Notification System
Mallinckrodt Pharmaceuticals with 10 CFR 20.2201(a)(1)(ii)
WEEKMONTHYEAR2015-06-19T05:00:00 [Table view]
[ENS list for Mallinckrodt Pharmaceuticals]

Navigation menu